CORBF (Global Cord Blood) DeferredTaxAndRevenue: $72.2 Mil (As of Mar. 2022)


CORBF Global Cord Blood Corp CORBF
12 GF Score
Price $0.95
View Full Analysis

What is Global Cord Blood DeferredTaxAndRevenue?

Global Cord Blood CORBF 12 DeferredTaxAndRevenue is $72.2 Mil as of Mar. 2022. GuruFocus rates CORBF with a GF Score™ of 12/100.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Global Cord Blood's current deferred tax and revenue for the quarter that ended in Mar. 2022 was $72.2 Mil.

Global Cord Blood DeferredTaxAndRevenue Related Terms

Global Cord Blood DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Global Cord Blood's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Cord Blood DeferredTaxAndRevenue Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.99 68.83 57.37 69.02 72.23

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.02 70.61 69.86 70.96 72.23
CORBF
12GF Score
Global Cord Blood Corp CORBF
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $72.2 Mil mean?
Global Cord Blood (CORBF) has a DeferredTaxAndRevenue of $72.2 Mil as of Mar. 2022. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Global Cord Blood.
Is Global Cord Blood's DeferredTaxAndRevenue too high?
Global Cord Blood's current DeferredTaxAndRevenue is $72.2 Mil. Overall, Global Cord Blood has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Global Cord Blood's DeferredTaxAndRevenue compare to PRE and LMDX?
Global Cord Blood's DeferredTaxAndRevenue of $72.2 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Diagnostics & Research company?
A good DeferredTaxAndRevenue depends on the Medical Diagnostics & Research industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Global Cord Blood. Global Cord Blood's current DeferredTaxAndRevenue is $72.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Cord Blood stock overvalued right now?
Global Cord Blood (CORBF) has a current DeferredTaxAndRevenue of $72.2 Mil. The current DeferredTaxAndRevenue is $72.2 Mil. Global Cord Blood's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Global Cord Blood (CORBF), the current DeferredTaxAndRevenue is $72.2 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Cord Blood Business Description

Address 1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants. The company generates all of its revenues by providing subscribers with processing services, which consist of the testing and processing of cord blood units, and storage services, which consist of the storage of cord blood units in its facilities.
12GF Score

Get the complete analysis for CORBF

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price